Escrito por estudiantes que aprobaron Inmediatamente disponible después del pago Leer en línea o como PDF ¿Documento equivocado? Cámbialo gratis 4,6 TrustPilot
logo-home
Document preview thumbnail
Vista previa 4 fuera de 51 páginas
Examen

NR603 CEA Exam 100+ (2026) 100% Correct Q&A with Rationales Full Bank

Document preview thumbnail
Vista previa 4 fuera de 51 páginas

NR603 CEA Exam 100+ (2026) 100% Correct Q&A with Rationales Full Bank. NR603 Exam Questions, CEA Exam 2026, NR603 CEA Study Guide, Nursing Exam Questions, CEA Exam Prep, NR603 Test Bank, Nursing Certification Exam

Vista previa del contenido

NR603 CEA EXAM · 100+ (2026) 100% CORRECT Q&A WITH RATIONALES | FU… EXAM


P R O F E S S I O N A L P R A C T I C E M AT E R I A L S




NR603 CEA Exam
100+ (2026) 100% Correct Q&A with Rationales | Full Bank

Verified Answers Exam Ready With Rationales 100 Questions


DOCUMENT OVERVIEW
This document, "NR603 CEA Exam," contains 100 multiple-choice questions with their correct answers and
detailed explanations, covering topics such as burn assessment, autoimmune disorder management, common
infections, thrombosis therapy, hormone replacement, leukemia treatment, endocrine disorders like
hyperthyroidism and diabetes mellitus complications, and mental health conditions including bipolar disorder
and PTSD. Students can effectively utilize this resource for in-depth review, understanding the rationale behind
correct answers and reinforcing key concepts for exam preparation.


E XA M Q U EST I O N S


Q1 QUESTION 1 OF 100
When utilizing the rule of palms to estimate the percentage of total body surface area affected by burns,
one palm surface area represents what percentage?
A) 3%
B) 0.5%
C) 1%
D) 2%
CORRECT ANSWER

C) 1%



Page 1

, RATIONALE
The rule of palms is a quick estimation method where each palm represents approximately 1% of the patient's
total body surface area, crucial for documenting burn extent.



Q2 QUESTION 2 OF 100
In the management of chronic autoimmune disorders, medications are often prescribed to control the
underlying disease process, differentiating them from treatments focused solely on symptom
exacerbation. Which pharmaceutical agent class is primarily utilized for this long-term disease
modification in most autoimmune conditions?
A) Corticosteroids
B) Monoclonal antibodies
C) Nonsteroidal anti-inflammatory drugs
D) Disease-modifying antirheumatic drugs
CORRECT ANSWER

B) Monoclonal antibodies

RATIONALE
Monoclonal antibodies target specific immune system components involved in the autoimmune process,
offering disease-modifying effects, whereas other options primarily address inflammation or symptoms.



Q3 QUESTION 3 OF 100
A 19-year-old female presents with dysuria and urinary frequency. Urinalysis reveals positive leukocyte
esterase, nitrates, WBCs, and bacteria. Her history includes a severe allergic reaction to an antibiotic two
years ago. Which antibiotic agent is most appropriate to initiate for this likely urinary tract infection?
A) Ciprofloxacin
B) Sulfamethoxazole/trimethoprim
C) Nitrofurantoin
D) Amoxicillin
CORRECT ANSWER

B) Sulfamethoxazole/trimethoprim


Page 2

, RATIONALE
Sulfamethoxazole/trimethoprim is a first-line agent for uncomplicated UTIs, but a severe allergic reaction history
contraindicates its use, requiring selection of an alternative agent like nitrofurantoin or ciprofloxacin.



Q4 QUESTION 4 OF 100
A patient diagnosed with a deep vein thrombosis (DVT) is learning about their prescribed anticoagulant
therapy. The nurse is assessing the patient’s understanding of bridging therapy. Which statement by the
patient indicates adequate comprehension?
A) "I will stop taking warfarin once my Lovenox injection is given."
B) "My INR needs to be below 2.0 before I can start Lovenox."
C) "I understand that warfarin is taken daily, and Lovenox is only for emergencies."
D) "I will continue Lovenox with warfarin until my INR reaches 3.0."
CORRECT ANSWER

D) "I will continue Lovenox with warfarin until my INR reaches 3.0."

RATIONALE
Bridging therapy involves overlapping warfarin with a parenteral anticoagulant like Lovenox until therapeutic
anticoagulation (INR 2.0-3.0) is achieved, demonstrating the patient's understanding of the concurrent
treatment duration and target INR.



Q5 QUESTION 5 OF 100
A 22-year-old trans female patient discontinues their prescribed hormone replacement therapy due to
insurance issues and presents to the clinic with symptoms of hypotension, pallor, and hypothermia. If the
patient was also prescribed prednisone for another condition, which of the following symptoms is MOST
directly attributable to abrupt prednisone withdrawal?
A) Increased appetite
B) Fluid retention
C) Agitation
D) Lethargy
CORRECT ANSWER

D) Lethargy

Page 3

, RATIONALE
Abrupt cessation of corticosteroids like prednisone can lead to adrenal insufficiency, manifesting as profound
fatigue, weakness, and lethargy due to the body's inability to produce sufficient cortisol. This contrasts with other
potential withdrawal symptoms or side effects of different medications.



Q6 QUESTION 6 OF 100
A 55-year-old female patient diagnosed with acute myeloid leukemia is undergoing chemotherapy. Which
medication is indicated to manage a common and serious side effect of this treatment regimen?
A) Ondansetron
B) Allopurinol
C) Granisetron
D) Loperamide
CORRECT ANSWER

B) Allopurinol

RATIONALE
Allopurinol is used to prevent hyperuricemia by inhibiting xanthine oxidase, a critical enzyme in purine
metabolism, thereby reducing the risk of tumor lysis syndrome in patients with acute myeloid leukemia.
Ondansetron and granisetron are antiemetics, and loperamide is an antidiarrheal.



Q7 QUESTION 7 OF 100
A female patient presents to the clinic with a history of intermittent, severe unilateral headaches
accompanied by nausea and photophobia. The nurse understands that the likely pharmacologic
management for this patient's acute migraine attack, based on established therapeutic principles, would
involve the administration of:
A) A beta-adrenergic antagonist
B) An opioid analgesic
C) A serotonin 5-HT1B/1D receptor agonist
D) A non-steroidal anti-inflammatory drug
CORRECT ANSWER

C) A serotonin 5-HT1B/1D receptor agonist

Page 4

Información del documento

Subido en
16 de junio de 2026
Número de páginas
51
Escrito en
2025/2026
Tipo
Examen
Contiene
Preguntas y respuestas
$14.45

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Seller avatar
Los indicadores de reputación están sujetos a la cantidad de artículos vendidos por una tarifa y las reseñas que ha recibido por esos documentos. Hay tres niveles: Bronce, Plata y Oro. Cuanto mayor reputación, más podrás confiar en la calidad del trabajo del vendedor.
LectScotty
4.1
(21)
Vendido
110
Seguidores
4
Artículos
2698
Última venta
9 horas hace


Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes